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CBA/N mice express a  complex, X-linked immunodeficiency that  is manifested 
primarily in  the function of thymus-independent  (B)  lymphocytes (1,  2).  Animals 
inheriting this defect fail to respond to a number of thymus-independent (TI) antigens, 
called TI-2  antigens (3),  that include haptenated derivatives of Ficoll (4),  type III 
pneumococcal polysaccharide (2), polyinosinic-polycytidilic acid (5), phosphocholine 
(PC; 6, 7), dextran (8), and levan. The CBA/N defect is not restricted to TI antigens, 
however, because PC fails to elicit a response in CBA/N mice even when presented as 
t  thymus-dependent protein conjugate (7). In addition, the CBA/N defect is selective 
with respect to TI antigens because trinitrophenyl (TNP)-derivatized lipopolysaccha- 
ride  (LPS; 9), TNP-Streptococcus  pneumoniae (6)  and TNP-Brucella abortus (10),  called 
TI-1  antigens  (3),  effectively stimulate TNP-specific responses in mice bearing the 
immunodeficieney. 
It is of interest that many of the antigens to which CBA/N mice appear unresponsive 
are bacterial carbohydrates. Antigens of this type, in particular PC  and dextrans, 
have been  shown recently to elicit antibody responses largely restricted in mice to 
IgM and the rare IgG3 subclass (11).  For this reason we examined immunoglobulin 
isotype concentrations in  sera  from mice with  the  CBA/N  phenotype and  found 
preferential deficiencies of IgG3  and  IgM  which were  only partially corrected  by 
polyclonal activation with LPS. These results suggest that CBA/N mice may lack a 
population of B lymphocytes that contain most of the IgG3 precursors. The absence 
of this  cell  population  may be  the  cause  of the  observed  immunodeficiency or, 
alternatively, the absence of IgG3 precursor cells may be the result of their immuno- 
deficiency. 
Materials and Methods 
Animals and Immunizatwns.  CBA/N mice of both sexes, (CBA/N X DBA/2)F1 and (DBA/2 
X  CBA/N)Fa  male mice were obtained from  the Division of Research  Services, National 
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Institutes of Health. DBA/2 mice were obtained from The Jackson Laboratory, Bar Harbor, 
Maine.  Serum  samples  were  obtained  immediately before  and  6  d  after  intraperitoneal 
administration of 50 #g LPS (lipopolysaccharide B, Escherichia coli 0111: B4; Difco Laboratories, 
Detroit, Mich.). 
Serum lsotype Analysis.  Levels of IgM, IgA, IgG  1, IgG2a, IgG2b, and IgG3 immunoglobulins 
in individual mouse sera were determined by using a solid-phase  inhibition type radioimmu- 
noassay performed in microtiter plates (Cooke Laboratory Products Div., Dynatech Laborato- 
ries, Alexandria, Va.) as previously described (11). Specific antisera used in these assays were 
prepared in rabbits by immunization with mouse myeloma proteins and were rendered at least 
100-fold specific by appropriate absorption with myeloma proteins of other isotypes as described 
before (11). 
Anti-y3 was prepared by immunizing a rabbit with 250 lag of FLOPC-21  protein (y3, K; 
Litton Bionetics, Inc., Kensington, Md.) in complete Freund's adjuvant (CFA) i.p.;  1 mo later 
the animal was boosted with 600 lag of W5606  ('/3, X) in CFA and bled 1 mo later. The serum 
was absorbed with a Sepharose conjugate of the globulin fraction of serum from an MPC-11 
('/2b, K) bearing mouse.  When used in the radioimmunoassay at  1:8,000 dilution, maximum 
binding of x25I-J606 ('/3, K) was 15-30%. Inhibition of binding by myeloma proteins showed at 
least  1,000-fold specificity  for IgG3 compared to all other isotypes. 
lsotype-Specific Plaque-Forming Cell (PFC) Enumeration.  Spleen cells secreting IgM and IgG3 
immunoglobulins were detected by a modified hemolytic plaque assay (13) by using staphylo- 
coccal protein A-derivatized sheep erythrocytes (SRBC) and our isotype-specific rabbit antisera. 
Specificity of this assay system was verified by using a panel of mouse myeloma cells secreting 
each of the major mouse isotypes. Up to 60% of  J606 and M104 myeloma cells formed plaques 
when tested with anti-'/3 and anti-la antisera, respectively. However, essentially no plaques were 
observed with these reagents when tested against myelomas secreting any other isotype, even at 
cell densities of 1 ×  l0  s per slide. 
Results and Discussion 
Table I shows the IgG3 concentrations in nonimmune sera derived from CBA/N, 
DBA/2, and their hybrids. Both CBA/N male and female mice show exceedingly low 
circulating levels of IgG3, near the limits of detection. In contrast, DBA/2 and (DBA/ 
2  ×  CBA/N)Fx males, both of which possess the DBA/2 X  chromosome and which 
do  not  therefore  express  the  CBA/N  defect,  have  relatively  high  levels  of IgG3, 
approaching 200/~g/ml  in  14-mo-old mice.  (CBA/N  ×  DBA/2)F1  males,  that  are 
hemizygous for the  defective CBA/N  ×  chromosome, behave much like the homo- 
zygous CBA/N  mice and show low base-line levels of circulating IgG3. Even older 
individuals fail to express more than 20 ~g/ml of IgG3 antibodies. 
It has not been possible thus far to generate a  radioimmunoassay for mouse IgG3 
with >l,000-fold specificity. Thus, serum levels of IgG3 less than 5/~g/ml cannot be 
measured  because of cross-reactivity of other  isotypes with  the anti-y3  reagent.  To 
distinguish  between low levels of IgG3 and a  total absence of IgG3 in mice bearing 
the  CBA/N  defect,  stimulation  of  IgG3  secretion  was  attempted  by  using  LPS 
immunization. LPS is believed to stimulate B-cell proliferation and antibody secretion 
relatively nonspecifically (14). 
Fig.  1 shows the serum IgM, IgA, IgG1, IgG2a, IgG2b, and IgG3 concentrations as 
determined in nonimmune animals and in animals 6 d after LPS stimulation.  (CBA/ 
N  ×  DBA/2)F1  defective males show  relatively normal serum  levels of IgA, IgG1, 
IgG2a, and IgG2b immunoglobulins (left upper panel), but are strikingly deficient in 
IgM and  IgG3 isotypes  (right  upper panels).  In addition,  the serum  IgM levels in 
both defective and nondefective males are stimulated about  10-fold by LPS immu- 
nization,  IgG3  concentrations  increase  approximately  threefold  in  both  groups  of PERLMUTTER ET AL.  BRIEF  DEFINITIVE REPORT 
TABLE  I 
IgG3 Concentration in Normal Serum 
995 
Strain  Sex  Genotype*  Phenotype~  Num-  Age  IgG3 concen- 
ber  tration§ 
mo  #g/ml 
CBA/N  Male  xid/Y  Defective  12  2-3  6.0 4" 0.5 
CBA/N  Female  xid/xid  Defective  I1  2-3  7.8 .4 0.8 
DBA/2  Male  +__/Y  Normal  10  2-3  66.6 -4 2.6 
(CBA/N ×  DBA/2)F1  Male  xid_._./Y  Defective  17  2-3  5.1  .4 0.5 
(DBA/2 × CBA/N)FI  Male  +__/Y  Normal  17  2-3  36.8 .4 2.3 
CBA/N  Male  xid/Y  Defective  10  9  5.5 4- 1.4 
(CBA/N x  DBA/2)F1  Male  xid/Y  Defective  4  14  17.7 .4 7.0 
(DBA/2 × CBA/N)F1  Male  ±/Y  Normal  4  14  180.5 4- 45.0 
* CBA/N mice possess an X-chromosomal  gene, xid, which when present in the homozygous  or hemizygous 
form leads to the characteristic immune defect. 
:1: Defective denotes failure to respond to TI-2  antigen stimulation. 
§ Minimum value of IgG3 is 5/xg/ml because of cross-reactivity of anti-I,3 with other isotypes. Values 
shown have not been corrected for this cross-reactivity. 
animals. The relative proportions of each isotype in defective compared to nondefec- 
tive sera are shown in  the lower panel  of Fig.  1.  Clearly mice bearing the CBA/N 
defect differ little from phenotypically normal reciprocal males except with respect to 
the  serum  concentrations of IgM and  IgG3 immunoglobulins.  Decreased  levels  of 
serum IgM have been previously reported in CBA/N mice (2,  15). 
A more precise method of evaluating immunoglobulin production is to determine 
the number of cells  secreting the various isotypes. Fig. 2 shows the number of spleen 
ceils  secreting  IgM  and  IgG3  in  unstimulated  and  LPS-stimulated  defective  and 
nondefective mice. The deficiencies seen before in serum levels  of these isotypes are 
reflected by comparable deficiencies of isotype-secreting cells.  Although there are no 
detectable  IgG3-secreting cells  in  unstimulated  CBA/N or  (CBA/N  ×  DBA/2)F1 
male mouse spleens, LPS does stimulate significant responses. However, although the 
anti-,/3  facilitating serum is highly specific for isotype in the reverse plaque assay, it 
is more difficult to evaluate specificity for variable region determinants, because the 
panel  of myelomas  used  to  evaluate  specificity  must  of necessity  express  limited 
variable region determinants. 
Restriction of the CBA/N defect to IgM and IgG3 isotypes might be explained by 
arguing that the environmental antigens that are normally responsible for stimulation 
of persistent serum IgM and IgG3 titers are mainly bacterial carbohydrates, antigens 
to which CBA/N mice are unresponsive. Thus, the CBA/N immunodeficiency may 
not directly affect the appearance of IgG3-bearing B lymphocytes; the observed low 
circulating levels oflgM and IgG3 might simply reflect the range of antigens to which 
the CBA/N mouse is  unresponsive.  Alternatively the  central  defect  in  the CBA/N 
mouse strain  might  be  a  selective  deficiency in  stimulable  ceils  committed  to  the 
production of IgM and IgG3. 
On the other hand, the fact that  LPS treatment  of mice with  the CBA/N defect 
does not completely repair their deficiency in  IgG3 is not evidence that  the rate of 
appearance of lymphocytes that are precursors of IgG3 secreting cells  is abnormal in 
these  mice.  It  is  quite  likely  that  environmental  stimulation  with  polysaccharide 
antigens normally causes an expansion in IgG3 precursors, whereas cells from immune 996  PERLMUTTER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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Serum isotype levels in  (DBA/2  X  CBA/N)F]  and  (CBA/N  X  DBA/2)F]  male mice. 
Serum was collected before and 6  d  after LPS stimulation of groups of four to six defective and 
nondefective mice.  Upper  panels:  isotype  levels  in  serum as  determined  by  radioimmunoassay. 
Lower  panels:  relative concentration  (defective compared  to  nondefective mice)  of each  isotype 
before and after LPS stimulation. The relative amounts of IgM and IgG3 in the serum of normal 
and defective mice 4 and 8 d  after LPS treatment were similar to those at 0 and 6 d. It should be 
noted  that  the IgG3 levels in unstimulated mice of both  phenotypes are higher here than those 
shown in Table I. We have found a  consistent difference in IgG3 levels in animals maintained in 
different facilities, which probably reflects different environmental stimulants. H,  nondefective 
(DXC); 0-----0, defective (CXD); I,  before LPS, o, 6 d  after LPS. 
defective mice, because  they are  unresponsive  to  such  antigens,  fail  to  undergo  a 
similar environmental antigen-driven expansion. Indeed, contact of IgG3 precursors 
from defective mice with environmental polysaccharides may actually induce toler- 
ance in these cells (16). In either case, mice with the CBA/N defect would appear to 
have  diminished  numbers  of precursors of IgG3-secreting cells when  compared  to 
normal individuals. LPS stimulation, although it would increase their absolute IgG3 
levels should not change their expression of this isotype relative to similarly treated 
normal controls. 
Finally, it is interesting to speculate on the mechanism by which the responses to 
bacterial polysaccharides and certain related antigens might be largely confined to PERLMUTTER  ET AL.  BRIEF  DEFINITIVE REPORT  997 
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Fro.  2.  IgM- and IgG3-secreting  ceils in spleens of defective and nondefeetive mice. Spleens of 
defective and nondefective mice (in groups of three to nine per point) were assayed by reversed 
plaque assay for IgM and IgG3 secretion before and 6 d after LPS stimulation. O, IgM; O, IgG3. 
the  IgM  and  IgG3 classes.  We have previously demonstrated  that  many bacterial 
carbohydrate  antigens  elicit  antibody  responses  in  the  mouse  largely  restricted  to 
IgG3 (11). Our attempts to alter this subclass-restriction by carrier manipulation have 
been unsuccessful (11). This suggests that certain Vn regions are only expressed in the 
context of certain Ca regions. Inability to elaborate IgG3, perhaps a subclass (as yet 
unidentified)  of IgM, and the Vn regions that are ordinarily linked to these Cn genes 
might either explain the complex immunodeficiency of the CBA/N mouse or be an 
important consequence of a primary inability to respond to polysaccharide antigens. 
Summary 
CBA/N  mice express an X-linked  deficiency in  their antibody response to many 
bacterial carbohydrates;  we have shown recently that these antigens normally elicit 
antibody responses predominantly of the IgM and IgG3 isotypes. Here we demonstrate 
that mice with the CBA/N phenotype have preferential deficiencies of IgM and IgG3 
immunoglobulin expression, both when measured in serum and in cells secreting these 
isotypes, and that this deficiency is only partially corrected by polyclonal activation 
of B cells. This suggests that CBA/N mice may lack a  subpopulation of B cells that 
contains most of the IgG3 precursors. 998  PERLMUTTER  ET AL.  BRIEF DEFINITIVE REPORT 
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